Evaluating Treatment Patterns, Relapses, Healthcare Resource Utilization, and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naïve Patients

PURPOSE: Early diagnosis and treatment of multiple sclerosis (MS) with disease-modifying therapy (DMT) can reduce relapse number and severity, which has cost implications. We describe treatment patterns, healthcare utilization, and cost among MS patients newly initiating DMTs (index). PATIENTS AND M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clinicoecon Outcomes Res
Egile Nagusiak: Freeman, Leorah, Kee, Arianna, Tian, Marc, Mehta, Rina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2021
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837567/
https://ncbi.nlm.nih.gov/pubmed/33519217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S288296
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak